Transforming Health Diagnosis with Breath Analysis

PNOĒ is a healthtech startup revolutionizing diagnostics with its innovative breath analysis technology. Founded by Apostolos Atsalakis and Panos Papadiamantis, PNOĒ offers a 12-minute, non-invasive breath test that deciphers key biomarkers to provide a comprehensive overview of cardiopulmonary health. Initially aimed at professionals in gyms, dietetics, and therapy, PNOĒ now enhances the wellness journey of over 40,000 individuals globally, helping health experts tailor personalized nutrition and exercise plans. Trusted by professionals in over a thousand facilities, PNOĒ not only delivers advanced health insights but also empowers users to take charge of their wellbeing.

PNOĒ in Three:

• What problem is PNOĒ solving? PNOĒ addresses the need for comprehensive, non-invasive health diagnostics by using breath analysis to provide insights into cardiopulmonary health.

• What’s innovative about PNOĒ? PNOĒ’s breath analysis technology deciphers biomarkers in just 12 minutes, offering an easy and rapid way to assess health and guide personalized nutrition and exercise plans.

• Who can use PNOĒ? Health professionals, including gyms, dieticians, therapists, and individuals seeking to optimize their wellness journey, can benefit from PNOĒ's advanced diagnostics.

To date, the company is being used by over 2000 businesses, top-tier health professionals and trusted by professional athletes, including NBA players, ecognized by the Financial Times as one of the top 50 of the Americas' Fastest-Growing Companies 2023 (https://www.ft.com/americas-fastest-growing-companies-2023). PNOE is a Y Combinator graduate and has raised over $10 million, actively growing on a global scale, with presence across Europe, the US and Latin America. Their growth is further supported by the diversity of their customer base, spanning from sports teams to gyms and hotels, as well as the overarching application of the company's breath analysis solution.